Helen of Troy Limited reported unaudited consolidated earnings results for the third quarter and nine months ended November 30, 2014. For the quarter, the company reported sales revenue of $435.674 million compared to $380.730 million a year ago. Income before income taxes were $60.957 million compared to $46.893 million a year ago. Net income was $55.377 million compared to $37.524 million a year ago. Diluted EPS was $1.92 compared to $1.16 a year ago. EBITDA was $75.698 million compared to $58.109 million a year ago. Adjusted EBITDA was $77.025 million compared to $60.512 million a year ago. Foreign currency exchange rate fluctuations decreased reported net sales revenue by $2.8 million year-over-year. Operating income was $65.0 million compared to operating income of $49.4 million in the same period last year. On an adjusted basis for the third quarter of fiscal years 2015 and 2014, excluding amortization of intangible assets and nonâ cash share based compensation: adjusted operating income was $73.2 million compared to $57.2 million for the third quarter of fiscal year 2014. Adjusted income was $62.6 million, or $2.17 per diluted share, compared to $44.7 million, or $1.37 per diluted share, for the third quarter of fiscal year 2014.

For the nine months, the company reported sales revenue of $1,067.401 million compared to $1,004.633 million a year ago. Income before income taxes were $101.415 million compared to $92.880 million a year ago. Net income was $90.614 million compared to $75.233 million a year ago. Diluted EPS was $3.12 compared to $2.33 a year ago. EBITDA was $142.031 million compared to $125.662 million a year ago. Adjusted EBITDA was $159.181 million compared to $146.911 million a year ago. Foreign currency exchange rate fluctuations decreased reported net sales revenue by $2.1 million year-over-year. Operating income was $112.8 million, which includes $9.0 million in non-cash asset impairment charges related to certain trademarks in the Company's Personal Care segment. This is compared to operating income of $100.4 million in the same period last year. On an adjusted basis for the first nine months of fiscal years 2015 and 2014, excluding non-cash asset impairment charges, acquisition-related expenses, amortization of intangible assets and non cash share based compensation in both periods, as applicable: adjusted operating income was $148.3 million compared to $137.9 million for the first nine months of fiscal year 2014. Adjusted income was $121.9 million, or $4.19 per diluted share, compared to $110.2 million, or $3.41 per diluted share, for the first nine months of fiscal year 2014.

For fiscal year 2015, the Company has revised its expectation upward to reflect the higher than expected third quarter results. The company now expects net sales revenue excluding Healthy Directions in the range of $1.290 billion to $1.315 billion, and diluted EPS (GAAP) in the range of $3.88 to $3.98, which includes after-tax non-cash asset impairment charges of $0.28 per share. The company continues to expect projected sales and diluted EPS (GAAP) from the Healthy Directions acquisition to be in the range of $100 million to $105 million and $0.12 to $0.16, respectively, for the eight months included in fiscal year 2015 results. The Company now expects consolidated net sales revenue including Healthy Directions in the range of $1.390 to $1.420 billion and diluted EPS (GAAP) in the range of $4.00 to $4.14. The Company now expects adjusted diluted EPS (non-GAAP) excluding Healthy Directions to be in the range of $5.01 to $5.11, which excludes after-tax non-cash asset impairment charges, intangible asset amortization expense, and non-cash share-based compensation expense. The Company continues to expect adjusted diluted EPS (non-GAAP) for Healthy Directions to be in the range of $0.32 to $0.36, which excludes after-tax acquisition-related expenses, intangible asset amortization expense, and non-cash share-based compensation expense. The company now expects consolidated adjusted diluted EPS (non-GAAP) including Healthy Directions to be in the range of $5.33 to $5.47.